FDA Approves Boehringer Ingelheim’s JASCAYD as First PDE4B Inhibitor for Idiopathic Pulmonary Fibrosis Read more
Algen Biotechnologies and AstraZeneca Partner to Accelerate Immunology Drug Discovery Using AI and CRISPR Read more
FDA Grants Fast Track Designation to Bristol Myers Squibb’s Alzheimer’s Antibody BMS-986446 Read more
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients Read more
AstraZeneca and Daiichi Sankyo’s Enhertu Shows Strong Phase III Results in HER2-Positive Early Breast Cancer Read more
FDA Grants Priority Review to AstraZeneca and Daiichi Sankyo’s Enhertu for First-Line HER2-Positive Metastatic Breast Cancer Read more
Sanofi Boosts Sanofi Ventures with $625M to Accelerate Biotech and Digital Health Investments Read more